LINE

An innovative portfolio that utilizes the regenerative power of hyaluronic acid.

FIDIA’s WCT Approach: Weight, Concentration, Technology

Nearly all effects of hyaluronan observed in vitro and in vivo systems depend on its molecular weight and its concentration.

Fidia’s approach in developing the Hyal-System Line lies in the Weight – Concentration – Technology (WCT) Concept, that is the unique combination of these three variables exploit different structural and biological properties of HA, enabling each Hyal-System Line product to bring out different targeted benefits.

SYSTEM The WCT concept: Weight, Concentration, Technology

Nearly all effects of hyaluronan observed in vitro and in vivo systems depend on its molecular weight and its concentration.

Fidia’s approach in developing the Hyal-System Line lies in the Weight – Concentration – Technology (WCT) Concept, that is the unique combination of these three variables exploit different structural and biological properties of HA, enabling each Hyal-System Line product to bring out different targeted benefits.

THIS PAGE IS INTENDED ONLY FOR HEALTHCARE PROFESSIONALS

To access this page, please click YES if you are a healthcare professional.
If you are not a healthcare professional, select NO to exit.